ABEO Abeona Therapeutics
- 4.3100
- -0.1400-3.15%
- 4.2800
- -0.0300-0.70%
Abeona Therapeutics News
Abeona Therapeutics(ABEO.US) Director Buys US$51,799 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Director Alland Leila purchased 11,000 shares of common stock on May 16, 2024 at an average price of $4.709 for a total value of $51,799.Source: Announcement What is sta
Abeona Therapeutics Is Maintained at Overweight by Cantor Fitzgerald
Abeona Therapeutics Is Maintained at Overweight by Cantor Fitzgerald
Cantor Fitzgerald Maintains Overweight on Abeona Therapeutics, Lowers Price Target to $21
Cantor Fitzgerald analyst Kristen Kluska maintains Abeona Therapeutics (NASDAQ:ABEO) with a Overweight and lowers the price target from $28 to $21.
Abeona Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 360.53% Cantor Fitzgerald $28 → $21 Maintains Overweight 04/23/2024 689.47% Cantor Fitzgerald →
Abeona Therapeutics Inc (ABEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Advances ...
Q1 2024 Abeona Therapeutics Inc Earnings Call
Abeona Therapeutics Shares Are Trading Higher. The Company Reported Q1 Financial Results.
Abeona Therapeutics Shares Are Trading Higher. The Company Reported Q1 Financial Results.
ABEONA THERAPEUTICS INC. Q1 Loss Increases, Misses Estimates
Abeona Therapeutics Estimates That Its Current Cash And Cash Equivalents, Restricted Cash And Short-term Investments Of $62.7M, Credit Facility, And Proceeds Of $75M From Underwritten Offering In May Is Expected To Provide Cash Runway Into 2026
Abeona Therapeutics Estimates That Its Current Cash And Cash Equivalents, Restricted Cash And Short-term Investments Of $62.7M, Credit Facility, And Proceeds Of $75M From Underwritten Offering In May
Abeona Therapeutics Q1 2024 GAAP EPS $(1.16) Misses $(0.51) Estimate
Abeona Therapeutics Q1 2024 GAAP EPS $(1.16) Misses $(0.51) Estimate
Abeona Therapeutics | 10-Q: Quarterly report
Press Release: Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress BLA resubmission anticipated in second half of 2024 Closed $75 million underwritten offering in May, ex
Abeona Therapeutics 1Q Loss/Shr $1.16 >ABEO
Abeona Therapeutics 1Q Loss/Shr $1.16 >ABEO
Plunge for Elodie Raises $2.5M+ for Life-Saving Rare Disease Research in Just 7 Years
Celebrities, sports teams, schools and supporters across 20+ locations worldwide take polar plunges to raise awareness and funds for rare genetic skin disorder called EBNEW YORK, May 7, 2024 /PRNewsw
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND, May 07, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in
Abeona Therapeutics Shares Rise After Underwritten Offering Gets Priced
By Dean Seal Shares of Abeona Therapeutics jumped after the company's underwritten offering was priced to raise $75 million. The stock was up 21% at $4.92 in early trading. Shares are about 2% below
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
CLEVELAND, May 03, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) ("Abeona" or the "Company") today announced the pricing of an underwritten offering of 12,285,056 shares of its common stock and, in
Abeona Therapeutics(ABEO.US) Officer Buys US$32,000 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Officer Seshadri Vishwas purchased 10,000 shares of common stock on Apr 25, 2024 at an average price of $3.2 for a total value of $32,000.Source: Announcement What is st
Abeona Therapeutics(ABEO.US) Director Buys US$24,764 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Director Charles Faith L. purchased 7,550 shares of common stock on Apr 26, 2024 at an average price of $3.28 for a total value of $24,764.Source: Announcement What is s
Abeona Therapeutics(ABEO.US) Officer Buys US$27,864 in Common Stock
$Abeona Therapeutics(ABEO.US)$ Officer O'Malley Brendan M. purchased 8,600 shares of common stock on Apr 25, 2024 at an average price of $3.24 for a total value of $27,864.Source: Announcement What is
Analysis
Price Target
No Data
